SLGT-2 inhibitors

3 Big Stories Health-Care Investors Should Be Watching This Week
Motley Fool
Mon, 01/7/13 - 10:23 am
JNJ
Invokana
SLGT-2 inhibitors
diabetes
Forxiga
Bristol-Myers Squibb
Pfizer
Raptor Pharmaceuticals